Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.9K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.9K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

932
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
932
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

702
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
702
Preclinical Development: Overview01:28

Preclinical Development: Overview

6.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.1K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic neutrophilic leukemia with transformation to B-lymphoblastic leukemia.

Leukemia research·2026
Same author

Chromatin accessibility in stem cells unveils progressive transcriptional alterations in myelodysplastic syndrome.

Nature communications·2025
Same author

NGS-based quantitative typing to identify HLA loss relapse after allogeneic stem cell transplantation.

Leukemia research·2025
Same author

Unraveling the impact of crizotinib to promote megakaryopoiesis for alleviating thrombocytopenia in myelodysplastic neoplasms.

Leukemia·2025
Same author

HMGA2 promotes platelet-neutrophil complex formation and pulmonary tissue damage in myelodysplastic syndromes.

Blood vessels, thrombosis & hemostasis·2025
Same author

Genotype-integrated single-cell transcriptome analysis reveals the role of DDX41 pR525H in a patient with myelodysplastic neoplasms.

Scientific reports·2025

Related Experiment Video

Updated: Feb 21, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.4K

MDS: Recent progress in molecular pathogenesis and clinical aspects.

Hironori Harada1

  • 1Laboratory of Oncology, Department of Medical Science, Tokyo University of Pharmacy and Life Sciences.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|October 6, 2017
PubMed
Summary

Myelodysplastic syndromes (MDS) involve gene mutations affecting hematopoietic stem cells. Identifying these genetic abnormalities aids in MDS diagnosis, prognosis, and predicting treatment response.

Keywords:
5q− syndromeClonal hematopoiesis of indeterminate potential (CHIP)Familial myeloid neoplasmsGene mutations

More Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.3K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.7K

Related Experiment Videos

Last Updated: Feb 21, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.4K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.3K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.7K

Area of Science:

  • Hematology
  • Genetics
  • Oncology

Background:

  • Myelodysplastic syndromes (MDS) are hematopoietic stem cell disorders characterized by genetic abnormalities.
  • Next-generation sequencing has significantly advanced understanding of genotype-phenotype correlations in MDS.
  • Over 90% of MDS patients exhibit one or more gene mutations.

Purpose of the Study:

  • To explore the role of gene mutations in the pathogenesis of MDS.
  • To understand how genetic alterations contribute to disease progression from clonal hematopoiesis to acute myelogenous leukemia (AML).
  • To highlight the clinical utility of understanding MDS-associated gene abnormalities.

Main Methods:

  • Analysis of next-generation sequencing data to identify gene mutations in MDS patients.
  • Review of literature on genetic alterations in MDS, including RNA splicing, DNA methylation, histone modifications, and chromosomal abnormalities.
  • Examination of the sequential accumulation of mutations and their impact on disease evolution.

Main Results:

  • More than 50 gene mutations in various pathways (RNA splicing, DNA methylation, etc.) are implicated in MDS pathogenesis.
  • Mutations in RNA splicing and DNA methylation are often early, founding events, while others are subclonal.
  • RUNX1 mutations, though often subclonal, are crucial in familial MDS; chromosomal alterations like in 5q- syndrome also play a role.

Conclusions:

  • Gene mutations are central to MDS development and progression.
  • Understanding the specific genetic landscape of MDS patients offers valuable clinical insights.
  • Genetic profiling can inform diagnosis, prognosis, and personalized therapy selection for MDS.